0001493152-20-004349.txt : 20200319
0001493152-20-004349.hdr.sgml : 20200319
20200319170012
ACCESSION NUMBER: 0001493152-20-004349
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200317
FILED AS OF DATE: 20200319
DATE AS OF CHANGE: 20200319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Culley Brian M
CENTRAL INDEX KEY: 0001310683
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 20729167
MAIL ADDRESS:
STREET 1: 6725 MESA RIDGE ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc.
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTIME INC
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0306
4
2020-03-17
0
0000876343
Lineage Cell Therapeutics, Inc.
LCTX
0001310683
Culley Brian M
C/O LINEAGE CELL THERAPEUTICS, INC.
2173 SALK AVENUE, SUITE 200
CARLSBAD
CA
92008
1
1
0
0
President and CEO
Employee Stock Option (Right to Buy)
0.6919
2020-03-17
4
A
0
1233300
0.00
A
2030-03-17
Common Shares
1233300
1233300
D
One quarter of the options shall vest on March 17, 2021 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.
/s/ Chase C. Leavitt, as Attorney-in-Fact for Brian M. Culley
2020-03-19